June 6, 2017 / 11:51 AM / 5 months ago

BRIEF-AMRI to be acquired by the Carlyle Group and GTCR

June 6 (Reuters) - Albany Molecular Research Inc

* AMRI signs definitive agreement to be acquired by the Carlyle Group and GTCR for $21.75 per share in cash

* Deal for ‍$21.75 per share in cash.​

* Transaction will be financed through a combination of debt and equity financing

* Agreement was unanimously approved by AMRI’s board of directors which has recommended that shareholders vote in favor of transaction

* There is no financing condition to obligations of equity sponsors to consummate transaction​

* Carlyle and GTCR have received debt financing commitments to finance transaction Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below